| 
|
|
|
|
(240) 505-6518 or email sales@biomind.com
Please direct correspondence to:
Biomind LLC
1405 Bernerd Place, Rockville MD 20851
|
| |
|
Dr. Ben Goertzel
Chief Executive and Chief
Science Officer.
Ben has been involved in AI research
and application development since the late 1980’s.
He holds a PhD in mathematics from Temple University, and
over the period 1989-1997 he held several university faculty
positions in mathematics, computer science, and psychology,
in the US, New Zealand and Australia.
He is author of numerous research
papers and journalistic articles, a biography of Linus Pauling,
and five scholarly books dealing with topics in the cognitive
sciences, including Chaotic Logic (Plenum Press, 1994),
and Creating Internet Intelligence (Plenum Press, 2001).
Two technical books describing many of the concepts
underpinning the Biomind AI Engine, coauthored with Cassio
Pennachin, will be forthcoming in late 2005.
After publishing several papers on systems
biology in the 1990's, in 2000 Dr. Goertzel began serious
research into novel AI-driven methods of extracting patterns
from genomic and proteomic data, with an initial emphasis on
microarray data. Thus Biomind was born.
Cassio Pennachin
Chief Technology Officer.
Cassio has been leading software
development projects since the mid-1990's, in artificial
intelligence, bioinformatics, operations research and other
areas. Prior to the founding of Biomind, he led a team
developing mass spectrometry data analysis software for
Proteometrics. From 1998-2001 Cassio was the former VP of R&D at Webmind
Inc. , leading several projects in AI, data mining and information
retrieval.
|
Robert Bradbury
Founder and leader of Aieveos
Corporation and Aieveos Sciences Group, Robert has been
researching biological and nanotechnological approaches to
life extension since the early 1990's.
Dr. Aubrey de Grey
Perhaps the most innovative contemporary
researcher in the field of biogerontology, Dr.
de Grey currently carries out his research at the
Department of Genetics of the University of Cambridge.
For information on his work, see his Strategies
for Engineering Negligible Senescence website.
W. Davis Parker Jr., MD
Professor of Neurology and Pediatrics and
Head of the Division of Pediatric Neurology at the
University of Virginia Health System, Dr.
Parker is a foremost authority on mitochondrial genetics
and neurodegenerative disease.
Dr. Richard Scheuermann
Dr.
Scheuermann is the Director of the Division of Translational Pathology
at Southwestern Medical Center. His
research
is unusually diverse, spannning areas such as signal transduction,
lymphocyte homeostasis, cancer biology, immunology, bioinformatics,
database development, computational biology, molecular diagnostics, and
biodefense.
Rafal Smigrodzki, MD, PhD
A neurologist with expertise in
mitochondrial function, Dr. Smigrodzki is currently working
with Gencia Corporation in Charlottesville VA, researching
protofection and other approaches for manipulating the
mitochondrial genome.
|
|
